We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Theramex has informed the MHRA that some cartons of Evorel Sequi contain the incorrect combination of patches. An error at the packaging site means that a limited number of packs have the incorrect combination of Evorel 50 and Evorel Conti...
Details of all GPC transactions of £500 and over for 2014.
Flexible datasets where you can choose and change the area type and coverage of Census 2021 sexual orientation and gender identity data combined with other variables.
Choose and change the area type and coverage for Census 2021 data about households and families combining multiple variables. Variables are about demography and migration; ethnic group, national identity, language, and religion; housing; and Welsh language skills.
Details of all government procurement card transactions of £500 and over for 2018.
Details of all government procurement card transactions of £500 and over for 2017.
The combined grid square product provides basic 2011 Census statistics for a combination of 1 kilometre and 100 metre grid squares in Northern Ireland.
Paper by the Scientific Pandemic Influenza Group on Behaviours (SPI-B) for the Scientific Advisory Group for Emergencies (SAGE).
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Details of all government procurement card transactions of £500 and over for 2016.
This section shows how to translate user needs into policy and services and how you to work collaboratively with users and specialists
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).